Bellaspon - combined sedative drug with antispasmodic action.
Release form and composition
Available medication in the form of pills for oral administration, containing:
- 20 mg of phenobarbital;
- 0.3 mg ergotamine;
- 0.1 mg alkaloids of belladonna root.
Indications for use
According to the information given in the instructions for Bellaspon, this drug is intended for the treatment of:
- Nervosa, especially accompanied by severe autonomic disorders;
- Neuropathic disorders caused by somatic diseases;
- Neurotic conditions in menopause;
- Concussions (as part of complex therapy).
According to the instructions for Bellaspona, the use of this drug is contraindicated in:
- Pronounced impaired renal / liver function;
- Severe hypertension;
- Porphyrias, including in the anamnesis;
- Glaucoma in decompensation stage;
- The presence of hypersensitivity to any component of the drug and to barbiturates;
- Severe impaired cardiac function;
- Night anxiety caused by atherosclerosis of the brain;
- Respiratory failure;
- Alcohol, drug or drug addiction, including a history;
- Significant increase in body temperature;
- Prostatic hypertrophy;
- Severe anemia;
- Respiratory diseases involving airway obstruction;
- Pregnancy (especially in the first trimester);
In addition, Bellaspon is contraindicated in children under 6 years.
Dosing and Administration
Drops of Bellaspon should be taken orally for 1 pc. three times a day. In severe cases, an increase in the daily dose of up to 6 tablets, i.e. 2 pcs. three times a day.
Children 6-15 years, the drug is prescribed 1-2 tablets per day.
The duration of treatment is determined by the attending physician, depending on the clinical picture and the patient's condition. With prolonged use (more than 2 weeks), treatment can not be stopped abruptly, the dosage should be gradually reduced, because The drug is addictive.
According to patient reviews, Bellaspon can have side effects such as:
- Paresthesia, reduced visual acuity, mild mental disorders;
- Itching, skin rashes, urticaria.
In addition, there are separate reports of the occurrence of the following undesirable effects: dry mouth, nausea, drowsiness, vomiting, constipation, loss of taste and / or appetite, edema, muscle weakness, cyanosis, and in elderly patients misting of consciousness. With prolonged use, there is a risk of developing drug dependence, which is why it is recommended to cancel Bellaspon gradually.
If you exceed the dosage recommended by your doctor, you may develop overdose symptoms such as nausea, chills, thirst, diarrhea, vomiting, unconsciousness, convulsions, cardiovascular disorders, or peripheral vasoconstriction. It is important to know that severe overdose can lead to coma with hypotension, significant suppression of the cardiovascular system, renal failure, shock and even death. If you accidentally take too large a dose of Bellaspon, you should do a gastric lavage and immediately call an ambulance. In case of severe poisoning, supportive therapy is prescribed to maintain adequate activity of the respiratory system, kidneys and cardiovascular system, as well as to support electrolyte balance.
Chronic intoxication may occur in people who are hypersensitive to the components of the drug. It is characterized by serious circulatory disorders and trophic disorders, arrhythmias, anginal pain, convulsions, changes in blood pressure, confusion of consciousness. In this case, you should stop taking Bellaspona and, if necessary, carry out symptomatic treatment.
During the use of Bellaspona, you should refrain from performing potentially hazardous types of work that require increased attention, visual acuity, high speed of psychophysical reactions and coordination of movements, especially for drivers of vehicles and people servicing mechanisms and working at height.
During the period of treatment with this drug is prohibited to consume alcoholic beverages.
Elderly patients, patients with anemia and hyperthyroidism are prescribed the drug, carefully comparing the expected benefits and potential risks.
Bellaspon suppresses or at least significantly weakens the effect of oral contraceptives, sex hormones, indirect anticoagulants, cardiac glycosides, timoleptic, quinidine, doxycycline.
This medication should not be used simultaneously with cyclophosphamide, chloral hydrate, methotrexate, petidine and 6-mercaptopurine, since Bellaspon enhances not only their effect, but also toxicity.
The action of one of the active components of Bellaspona - phenobarbital:
- Enhance - ethanol, hydantoin, MAO inhibitors, valproic acid, oral antidiabetic drugs and acidifying urine;
- Reduce cholestyramine, antacids, phenylbutazone and urine alkalizing drugs.
With the constant use of Bellaspon in doses 3-4 times higher than the recommended therapeutic, 75% of patients develop physical dependence.
There are no structural analogues for Bellasponn. The following drugs are similar in their mechanism of action: Adonis-Brom, Alluna, Quite, Novo-Pasit, Nota, Sedasen, Sedative Pts, Soothing collection, Schmiellik of the Baikal extract.
Terms and conditions of storage
Bellaspon is a sedative drug that is sold in pharmacies only with a doctor’s prescription. It should be stored in a dry place inaccessible to the sun, at temperatures up to 25 ºС. If these conditions are met, the dough life is 3 years.